JPMorgan analyst Tami Zakaria upgraded Middleby (MIDD) to Neutral from Underweight with a price target of $125, down from $140. The firm’s updated EBITDA estimates remain 7% below consensus for both fiscal 2026 and 2027, but it believes the stock’s current valuation reflects a balanced risk/reward “against muted expectations.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIDD:
- Middleby Corporation Surpasses Q3 Expectations Amid Strategic Review
- Middleby Reports Strong Q3 Despite Challenges
- Middleby Hold Rating: Awaiting Clarity on Strategic Review and Market Signals
- Middleby sees Q4 adjusted EPS $2.19-$2.34, consensus $2.34
- Middleby raises FY25 adjusted EPS view to $8.99-$9.14 from $8.65-$9.05